Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) saw a significant decrease in short interest in the month of July. As of July 31st, there was short interest totaling 362 shares, a decrease of 48.5% from the July 15th total of 703 shares. Based on an average trading volume of 2,039 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the shares of the company are short sold.
Gyrodyne Trading Up 1.5%
NASDAQ:GYRO traded up $0.08 on Monday, hitting $5.48. The stock had a trading volume of 5,612 shares, compared to its average volume of 2,379. The business’s 50-day simple moving average is $5.88 and its two-hundred day simple moving average is $7.27. Gyrodyne has a 52-week low of $5.31 and a 52-week high of $11.00.
Institutional Trading of Gyrodyne
An institutional investor recently bought a new stake in Gyrodyne stock. Advisory Services Network LLC purchased a new position in Gyrodyne , LLC (NASDAQ:GYRO – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 7,720 shares of the real estate investment trust’s stock, valued at approximately $77,000. Advisory Services Network LLC owned 0.35% of Gyrodyne at the end of the most recent quarter. Hedge funds and other institutional investors own 71.36% of the company’s stock.
About Gyrodyne
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Featured Stories
- Five stocks we like better than Gyrodyne
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
